Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole)

N. Principi, P. Marchisio, A. Biasini, A. Dalla Villa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The incidence of hematologic abnormalities was evaluated in 120 children with otitis media treated respectively with cotrimoxazole (trimethoprim-sulfamethoxazole) (group 1), cotrimoxazole plus folinic acid (group 2) and amoxicillin (group 3) in therapeutic doses for ten days. Only eosinophilia (an absolute count ≥ 0.5 x 109/l) (group 1=10%, 2=5%, 3=7.5%) and neutropenia (polymorphonuclear neutrophilic leucocyte count ≤1.5 x 109/1) (group 1=35%, 2=17.5%, 3=13.3%) were noted. Early neutropenia (evident on the 5th day of therapy) occurred in all the treatment groups, thus it is not related to cotrinoxazole administration and in most cases neutrophil count reversed to normal in few days without drug discontinuation. Late neutropenia (evident after 10 days of treatment) appeared only in cotrimoxazole treated children (p

Original languageEnglish
Pages (from-to)763-767
Number of pages5
JournalActa Paediatrica Scandinavica
Volume73
Issue number6
Publication statusPublished - 1984

Fingerprint

Sulfamethoxazole Drug Combination Trimethoprim
Neutropenia
Neutrophils
Leucovorin
Amoxicillin
Otitis Media
Eosinophilia
Therapeutics
Leukocyte Count
Incidence
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole). / Principi, N.; Marchisio, P.; Biasini, A.; Dalla Villa, A.

In: Acta Paediatrica Scandinavica, Vol. 73, No. 6, 1984, p. 763-767.

Research output: Contribution to journalArticle

@article{16c5579ca62142608fc794f95cf41a7c,
title = "Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole)",
abstract = "The incidence of hematologic abnormalities was evaluated in 120 children with otitis media treated respectively with cotrimoxazole (trimethoprim-sulfamethoxazole) (group 1), cotrimoxazole plus folinic acid (group 2) and amoxicillin (group 3) in therapeutic doses for ten days. Only eosinophilia (an absolute count ≥ 0.5 x 109/l) (group 1=10{\%}, 2=5{\%}, 3=7.5{\%}) and neutropenia (polymorphonuclear neutrophilic leucocyte count ≤1.5 x 109/1) (group 1=35{\%}, 2=17.5{\%}, 3=13.3{\%}) were noted. Early neutropenia (evident on the 5th day of therapy) occurred in all the treatment groups, thus it is not related to cotrinoxazole administration and in most cases neutrophil count reversed to normal in few days without drug discontinuation. Late neutropenia (evident after 10 days of treatment) appeared only in cotrimoxazole treated children (p",
author = "N. Principi and P. Marchisio and A. Biasini and {Dalla Villa}, A.",
year = "1984",
language = "English",
volume = "73",
pages = "763--767",
journal = "Acta Paediatrica Scandinavica",
issn = "0001-656X",
publisher = "Taylor and Francis Ltd.",
number = "6",

}

TY - JOUR

T1 - Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole)

AU - Principi, N.

AU - Marchisio, P.

AU - Biasini, A.

AU - Dalla Villa, A.

PY - 1984

Y1 - 1984

N2 - The incidence of hematologic abnormalities was evaluated in 120 children with otitis media treated respectively with cotrimoxazole (trimethoprim-sulfamethoxazole) (group 1), cotrimoxazole plus folinic acid (group 2) and amoxicillin (group 3) in therapeutic doses for ten days. Only eosinophilia (an absolute count ≥ 0.5 x 109/l) (group 1=10%, 2=5%, 3=7.5%) and neutropenia (polymorphonuclear neutrophilic leucocyte count ≤1.5 x 109/1) (group 1=35%, 2=17.5%, 3=13.3%) were noted. Early neutropenia (evident on the 5th day of therapy) occurred in all the treatment groups, thus it is not related to cotrinoxazole administration and in most cases neutrophil count reversed to normal in few days without drug discontinuation. Late neutropenia (evident after 10 days of treatment) appeared only in cotrimoxazole treated children (p

AB - The incidence of hematologic abnormalities was evaluated in 120 children with otitis media treated respectively with cotrimoxazole (trimethoprim-sulfamethoxazole) (group 1), cotrimoxazole plus folinic acid (group 2) and amoxicillin (group 3) in therapeutic doses for ten days. Only eosinophilia (an absolute count ≥ 0.5 x 109/l) (group 1=10%, 2=5%, 3=7.5%) and neutropenia (polymorphonuclear neutrophilic leucocyte count ≤1.5 x 109/1) (group 1=35%, 2=17.5%, 3=13.3%) were noted. Early neutropenia (evident on the 5th day of therapy) occurred in all the treatment groups, thus it is not related to cotrinoxazole administration and in most cases neutrophil count reversed to normal in few days without drug discontinuation. Late neutropenia (evident after 10 days of treatment) appeared only in cotrimoxazole treated children (p

UR - http://www.scopus.com/inward/record.url?scp=0021674459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021674459&partnerID=8YFLogxK

M3 - Article

VL - 73

SP - 763

EP - 767

JO - Acta Paediatrica Scandinavica

JF - Acta Paediatrica Scandinavica

SN - 0001-656X

IS - 6

ER -